Hair cortisol as a biological marker of chronic stress: current status, future directions and unanswered questions E Russell, G Koren, M Rieder, S Van Uum Psychoneuroendocrinology 37 (5), 589-601, 2012 | 1200 | 2012 |
Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study NA Kulin, A Pastuszak, SR Sage, B Schick-Boschetto, G Spivey, ... Jama 279 (8), 609-610, 1998 | 629 | 1998 |
Reducing the pain of childhood vaccination: an evidence-based clinical practice guideline A Taddio, M Appleton, R Bortolussi, C Chambers, V Dubey, S Halperin, ... Cmaj 182 (18), E843-E855, 2010 | 536 | 2010 |
Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester SJ Jacobson, L Ceolin, P Kaur, A Pastuszak, T Einarson, G Koren, ... The Lancet 339 (8792), 530-533, 1992 | 464 | 1992 |
Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children H Visscher, CJD Ross, SR Rassekh, A Barhdadi, MP Dubé, H Al-Saloos, ... Journal of clinical oncology 30 (13), 1422-1428, 2012 | 445 | 2012 |
More codeine fatalities after tonsillectomy in North American children LE Kelly, M Rieder, J van den Anker, B Malkin, C Ross, MN Neely, ... Pediatrics 129 (5), e1343-e1347, 2012 | 437 | 2012 |
An assessment of cortisol analysis in hair and its clinical applications R Gow, S Thomson, M Rieder, S Van Uum, G Koren Forensic science international 196 (1-3), 32-37, 2010 | 436 | 2010 |
Regulation of cytokine and cytokine receptor expression by glucocorticoids WY Almawi, HN Beyhum, AA Rahme, MJ Rieder Journal of leukocyte biology 60 (5), 563-572, 1996 | 423 | 1996 |
Reducing pain during vaccine injections: clinical practice guideline A Taddio, CM McMurtry, V Shah, RP Riddell, CT Chambers, M Noel, ... Cmaj 187 (13), 975-982, 2015 | 368 | 2015 |
Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy CJD Ross, H Katzov-Eckert, MP Dubé, B Brooks, SR Rassekh, ... Nature genetics 41 (12), 1345-1349, 2009 | 365 | 2009 |
Inadequate pain management during routine childhood immunizations: the nerve of it A Taddio, CT Chambers, SA Halperin, M Ipp, D Lockett, MJ Rieder, ... Clinical therapeutics 31, S152-S167, 2009 | 364 | 2009 |
Diagnosis of sulfonamide hypersensitivity reactions by in-vitro" rechallenge" with hydroxylamine metabolites MJ Rieder, J Uetrecht, NH Shear, M Cannon, M Miller, SP Spielberg Annals of internal medicine 110 (4), 286-289, 1989 | 286 | 1989 |
Hair analysis provides a historical record of cortisol levels in Cushing's syndrome S Thomson, G Koren, LA Fraser, M Rieder, TC Friedman, SHM Van Uum Experimental and Clinical Endocrinology & Diabetes 118 (02), 133-138, 2010 | 280 | 2010 |
A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer F Aminkeng, AP Bhavsar, H Visscher, SR Rassekh, Y Li, JW Lee, ... Nature genetics 47 (9), 1079-1084, 2015 | 271 | 2015 |
Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions MJ Rieder, NH Shear, A Kanee, BK Tang, SP Spielberg Clinical Pharmacology & Therapeutics 49 (1), 13-17, 1991 | 257 | 1991 |
Hair cortisol analysis: An update on methodological considerations and clinical applications MJE Greff, JM Levine, AM Abuzgaia, AA Elzagallaai, MJ Rieder, ... Clinical biochemistry 63, 1-9, 2019 | 232 | 2019 |
Recommendations for genetic testing to reduce the incidence of anthracycline‐induced cardiotoxicity F Aminkeng, CJD Ross, SR Rassekh, S Hwang, MJ Rieder, AP Bhavsar, ... British journal of clinical pharmacology 82 (3), 683-695, 2016 | 226 | 2016 |
Hair cortisol and the risk for acute myocardial infarction in adult men D Pereg, R Gow, M Mosseri, M Lishner, M Rieder, S Van Uum, G Koren Stress 14 (1), 73-81, 2011 | 221 | 2011 |
Bronchiolitis: recommendations for diagnosis, monitoring and management of children one to 24 months of age JN Friedman, MJ Rieder, JM Walton, Canadian Paediatric Society, ... Paediatrics & child health 19 (9), 485-491, 2014 | 217 | 2014 |
Recommendations for HLA‐B* 15: 02 and HLA‐A* 31: 01 genetic testing to reduce the risk of carbamazepine‐induced hypersensitivity reactions U Amstutz, NH Shear, MJ Rieder, S Hwang, V Fung, H Nakamura, ... Epilepsia 55 (4), 496-506, 2014 | 210 | 2014 |